MTOR and cancer: Moreover, mTOR inhibitors, metformin and rapamycin, enhanced cytotoxicity of anti-cancer agents in p53-mutated tumors but rather protected normal cells with the wild-type p53 from the drug-induced cytotoxicity [20].